What is the current valuation of the South America biotechnology pharmaceutical services outsourcing market?

As of 2024, the market valuation was 5.37 USD Billion. Read More

What is the projected market size for the South America biotechnology pharmaceutical services outsourcing market by 2035?

The market is expected to reach 8.72 USD Billion by 2035. Read More

Which companies are considered key players in the South America biotechnology pharmaceutical services outsourcing market?

Key players include Laboratorio Elea Phoenix, Grupo Biotoscana, AstraZeneca, Boehringer Ingelheim, Novartis, Roche, Merck, Pfizer, and GSK. Read More

What are the main application segments in the South America biotechnology pharmaceutical services outsourcing market?

Main application segments include Drug Development, Clinical Trials, Regulatory Affairs, Market Access, and Pharmacovigilance. Read More

How did the Drug Development segment perform in terms of valuation from 2024 to 2026?

The Drug Development segment increased from 1.5 USD Billion in 2024 to a projected 2.4 USD Billion in 2026. Read More

What is the valuation of the Clinical Trials segment in 2026?

The Clinical Trials segment is projected to reach 1.9 USD Billion in 2026. Read More

Which therapeutic area is expected to have the highest valuation in the South America biotechnology pharmaceutical services outsourcing market by 2035?

Oncology is expected to have the highest valuation, projected at 2.5 USD Billion by 2035. Read More

What is the expected growth in the Contract Research Organization segment from 2024 to 2026?

The Contract Research Organization segment is anticipated to grow from 1.5 USD Billion in 2024 to 2.4 USD Billion in 2026. Read More

South America Biotechnology Pharmaceutical Services Outsources Market

Q: What is the expected CAGR for the South America biotechnology pharmaceutical services outsourcing market during the forecast period 2025 - 2035?

The expected CAGR for this market is 4.5% during the forecast period. Read More

Q: How do the client types in the South America biotechnology pharmaceutical services outsourcing market compare in terms of valuation?

Pharmaceutical Companies are projected to lead with a valuation of 4.25 USD Billion by 2035, followed by Biotechnology Firms at 1.73 USD Billion. Read More

ID: MRFR/Pharma/50546-HCR

200 Pages

Vikita Thakur

Last Updated: February 06, 2026

South America Biotechnology Pharmaceutical Services Outsourced Market Research Report By Service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education, Others), By End-use (Pharmaceutical, Biotechnology), and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth & Industry Forecast 2025 To 2035

South America Biotechnology Pharmaceutical Services Outsources Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Drug Development
  2. 4.1.2 Clinical Trials
  3. 4.1.3 Regulatory Affairs
  4. 4.1.4 Market Access
  5. 4.1.5 Pharmacovigilance
2. 4.2 Healthcare, BY Service Type (USD Billion)
  1. 4.2.1 Contract Research Organization
  2. 4.2.2 Contract Manufacturing Organization
  3. 4.2.3 Contract Development and Manufacturing Organization
  4. 4.2.4 Consulting Services
  5. 4.2.5 Laboratory Services
3. 4.3 Healthcare, BY Therapeutic Area (USD Billion)
  1. 4.3.1 Oncology
  2. 4.3.2 Cardiovascular
  3. 4.3.3 Neurology
  4. 4.3.4 Infectious Diseases
  5. 4.3.5 Metabolic Disorders
4. 4.4 Healthcare, BY Client Type (USD Billion)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Firms
  3. 4.4.3 Academic Institutions
  4. 4.4.4 Government Agencies
  5. 4.4.5 Non-Profit Organizations
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Laboratorio Elea Phoenix (AR)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Grupo Biotoscana (BR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 AstraZeneca (BR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boehringer Ingelheim (BR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Novartis (BR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Roche (BR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Merck (BR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Pfizer (BR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GSK (BR)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY SERVICE TYPE
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY CLIENT TYPE
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
16. 6.16 HEALTHCARE, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Billion)
18. 6.18 HEALTHCARE, BY CLIENT TYPE, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY CLIENT TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY SERVICE TYPE, 2026-2035 (USD Billion)
  3. 7.2.3 BY THERAPEUTIC AREA, 2026-2035 (USD Billion)
  4. 7.2.4 BY CLIENT TYPE, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2022-2035)

Drug Development
Clinical Trials
Regulatory Affairs
Market Access
Pharmacovigilance

Healthcare By Service Type (USD Billion, 2022-2035)

Contract Research Organization
Contract Manufacturing Organization
Contract Development and Manufacturing Organization
Consulting Services
Laboratory Services

Healthcare By Therapeutic Area (USD Billion, 2022-2035)

Oncology
Cardiovascular
Neurology
Infectious Diseases
Metabolic Disorders

Healthcare By Client Type (USD Billion, 2022-2035)

Pharmaceutical Companies
Biotechnology Firms
Academic Institutions
Government Agencies
Non-Profit Organizations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”